Clinical trial R2810-ONC-1676
An open-label, randomized, phase 3 clinical trial of REGN2810 versus investigator's choice of chemotherapy in recurrent or metastatic cervical carcinoma
| Cancers | |
|---|---|
| Organ | Uterus |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Regeneron Pharmaceuticals, Inc. |
| EudraCT Identifier | 2017-000350-19 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03257267 |
| Inclusion criteria | Recurrent, persistent, and/or metastatic |
| Last update |